Interdisciplinary and evidence-based treatment guideline for Juvenile Idiopathic Arthritis;Interdisziplinäre S2-Therapieleitlinie der Juvenilen Idiopathischen Arthritis

Klinische Padiatrie

Volumn 220, Issue 6, 2008, Pages 392-402

  Guellac, N ^a   Niehues, Tim ^a  

^a HELIOS KLINIKUM KREFELD   (Germany)

Author keywords

Adolescence; Children; Consensus; Evidence based medicine; Juvenile idiopathic arthritis; Treatment guideline

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CYCLOSPORIN A; DICLOFENAC; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GLUCOCORTICOID; IBUPROFEN; IMMUNOSUPPRESSIVE AGENT; INDOMETACIN; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; SALAZOSULFAPYRIDINE; TRIAMCINOLONE HEXACETONIDE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ARTICLE; CHILD HEALTH CARE; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HUMAN; INTERDISCIPLINARY RESEARCH; JUVENILE RHEUMATOID ARTHRITIS; LIVER TOXICITY; MASSAGE; MEDLINE; OCCUPATIONAL THERAPY; OFF LABEL DRUG USE; PHYSIOTHERAPY; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SOCIAL SUPPORT; STANDARDIZATION; TRANSCUTANEOUS NERVE STIMULATION;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; HUMANS; INFANT; PATIENT CARE TEAM;

EID: 56349145164     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1086037     Document Type: Article

References (70)

1. Adebajo A, Hall M. The use of intravenous pulsed methylprednisolone in the treatment of systemic-onset juvenile chronic arthritis. Br J Rheumatol 1998; 37: 1240-1242
2. Andreae J et al. Effect of glucocorticoid therapy on glucocorticoid receptors in children with autoimmune diseases. Pediatr Res 2001; 49: 130-135
3. April KT, Ehrmann Feldman ED, Platt RW et al. Comparison between children with juvenile idiopathic arthritis (JIA) and their parents concerning perceived quality of life. Quality of Life Research 2006; 15: 655-661
4. Arabshahi B, Dewitt EM, Cahill AM et al. Utility of corticosteroid injection for temporomandibular arthritis in children with juvenile idiopathic arthritis. Arthritis Rheum 2005; 52 (11): 3563-3569
5. Breit W et al. A sub-group specific evaluation of the efficacy of intraarticular triamcinolone hexacetonide in juvenile chronic arthritis. J Rheumatol 2000; 27: 2696-2702
6. Brewer EJ, Giannini EH, Kuzmina N et al. Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the USA - U.S.S.R. double-blind placebo-controlled trial. N Engl J Med 1986; 314: 1269-1276
7. Buttgereit F et al. Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis 2002; 61: 718-722
8. Buttgereit F. Mechanisms and clinical relevance of nongenomic glucocorticoid actions. Z Rheumatol 2000; 59 (Suppl. 2): 119-123
9. Cleary AG et al. Intra-articular corticoid injections in juvenile idiopathic arthritis. Arch Dis Child 2003; 88: 192-196
10. Jong Z De, Munneke M, Zwinderman AH et al. Is a long term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Results of a randomized controlled trial. Arthritis Rheum 2003; 48 (9): 2415-242
11. Encke A, Kopp I, Selbmann HK et al. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Ärztliches Zentrum für Qualität in der Medizin (ÄZQ), and Hrsg. Deutsches Instrument zur methodischen Bewertung von Leitlinien: DELBI. Dt Ärztebl 2005; 102 (26): A1912-A1913; www.delbi.de - Zugriff am 10.2.2008
12. Epps H, Ginnelly L, Utley M et al. Is hydrotherapy cost-effective? A randomised controlled trial of combined hydrotherapy programmes compared with physiotherapy land techniques in children with juvenile idiopathic arthritis. Health Technol Assess 2005; 9 (39): 1
13. Feldman BM, Grundland B, MacCullough L et al. Distinction of quality of life, health related quality of life, and health status in children referred for rheumatologic care. J Rheumatol 2000; 27: 226-233
14. Feldmann W. Evidence-based Pediatrics 1st ed. BC Decker, Hamilton; 2000
15. Fink CW. Overview of corticoid therapy in the different rheumatic diseases of childhood. Clin Exp Rheumatol 1991; 9 (Suppl 6): 9-13
16. Foeldvari I, Burgos-Vargas R, Thon A et al. High response rate in the phase I/II study of meloxicam in juvenile rheumatoid arthritis. J Rheumatol 2002; 29 (5): 1079-1083
17. Gao JS, Wu H, Tian J. Treatment of patients with juvenile rheumatoid arthritis with combination of leflunomide and methotrexate. Zhonghua Er Ke Za Zhi 2003; 41: 435-438
18. Giannini EH, Brewer EJ, Miller ML et al. Ibuprofen suspension in the treatment f juvenile rheumatoid arthritis Pediatric Rheumatology Study Group. J Pediatr 1990; 117: 645-652
19. Haapasaari J, Wuolijoki E, Ylijoki H. Treatment of juvenile rheumatoid arthritis with diclofenac sodium. Scand J Rheumatol 1983; 12: 325-330
20. Hebestreit H, Müller-Scholden J, Huppertz HI. Aerobic Fitness and Physical Activity in Patients with HLA B27 Positive Juvenile Spondylarthropathy that is Inactive or in Remission. J Rheumatol 1998; 25: 1626-1633
21. Hoffmann JC, Fischer I, Höhne W et al. Methodische Grundlagen für die Ableitung von Konsensusempfehlungen. Zeitschrift für Gastroenterologie 2004; 42 (9): 84-87
22. Horneff G, Forster J, Seyberth HW et al. Arbeitgemeinschaff Kinder- und Jugendrheumatologie. Recommendations by the Pediatric and Adolescent Rheumatology Study Committee on therapy with Etanercept (p75 TNF-alpha receptor immunoglobulin fusion protein. Pharmacotherapy Committee. Z Rheumatol 2000; 59 (6): 365-369
23. Horneff G, Schmeling H, Biedermann T, et al. Paediatric Rheumatology Collaborative Group: The German etanercept registry for treatment of juvenile idiopathic arthritis. Ann Rheum Dis 2004; 1: 1
24. Huppertz HI et al. Intraarticular corticosteroids for chronic arthritis in children: efficacy and effects on cartilage and growth. J Pediatr 1995; 127: 317-321
25. Jones G, Bennell K, Cicuttini F M. Effect of physical activity on cartilage development in healthy kids. Br J Sports Med 2003; 37 (5): 382-383
26. Kaiser H. Praxis der Cortisontherapie, ed. Kaiser, Urban und Schwarzenberg, München, 4. Auflage 1996
27. Katsicas MM, Russo RA. Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanercept. Clin Exp Rheumatol 2005; 23: 545-548
28. Kimura Y et al. High dose, alternate day corticosteroids for systemic onset juvenile rheumatoid arthritis. J Rheumatol 2000; 27: 2018-2024
29. Klepper SE. Effects of an Eight-Week Physical Conditioning Program on Disease Signs and Symptoms in Children with Chronic Arthritis. Arthritis Care and Research 1999; 12: 52-60
30. Kvien TK, Hoyeraal HM, Sandstad B. Azathioprine versus placebo in patients with juvenile rheumatoid arthritis: a single center double blind comparative study. J Rheumatol 1986; 13: 118-123
31. Kvien TK, Hoyeraal HM, Sandstad B. Naproxen and acetylsalicylic acid in the treatment of pauciarticular and polyarticular juvenile rheumatoid arthritis. Assessment of tolerance and efficacy in a single-centre 24-week double-blind parallel study. Scand J Rheumatol 1984; 13: 342-350
32. Langer HE. Patient education - a contribution to improvement of long-term management of patients with rheumatism. Z Rheumatol 1995; 54: 207-212
33. Laxer RM, Silverman ED, St-Cyr C et al. A six-month open safety assessment of a naproxen suspension formulation in the therapy of juvenile rheumatoid arthritis. Clin Ther 1988; 10: 381-387
34. Leak AM, Richter MR, Clemens LE et al. A crossover study of naproxen, diclofenac and tolmetin in seronegative juvenile chronic arthritis. Clin Exp Rheumatol 1988; 6: 157-160
35. Lequerré T et al. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann Rheum Dis 2008; 67 (3): 302-308. Epub 2007 Oct 18
36. Lovell DJ, Reiff A, Jones OY, et al. Pediatric Rheumatology Collaborative Study Group: Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum 2006; 1987-1994
37. Malleson P, Bennett SM, Mac Kinnon M et al. Physical Fitness and its Relationship to other Indices of Health Status in Children with Chronic Arthritis. J Rheumatol 1996; 23: 1059-1065
38. Manschwetus H. Quality standards and certification of patient education in rheumatology. Z Rheumatol 2003; 62: 1121-1123
39. Michels H. What is low dose corticosteroid therapy in juvenile idiopathic arthritis? A worldwide questionnaire-based survey. Z Rheumatal 2000; 59 (Suppl. 2): 127-130
40. Müller-Godeffroy E, Lehmann H, Küster et al. Lebensqualität und psychosoziale Anpassung bei Kindern und Jugendlichen mit juveniler idiopathischer Arthritis und reaktiven Arthritiden. Zeitschrift für Rheumatologie 2005; 64: 177-187
41. Niehues T, Horneff G, Michels H et al. Evidence-based use of methotrexate in children with rheumatic disorders. Consensus statement of the Working Group for Children and Adolescents with Rheumatic Diseases in Germany (AGKJR) and the Working Group. Pediatric Rheumatology Austria Z Rheumatol 2004; 63 (2): 147-158
42. Padeh S, Passwell JH. Intraarticular corticosteroid injection in the management of children with chronic arthritis. Arthritis Rheum 1998; 41: 1210-1214
43. Pistoia V, Buoncompagni A, Scribanis R. Cyclosporin A in the treatment of juvenile chronic arthritis and childhood polymyositis-dermatomyositis Results of a preliminary study. Clin Exp Rheumatol 1993; 11: 203-208
44. Powell M, Seid M, Szer IS. Efficacy of custom foot orthotics in improving pain and functional status in children with juvenile idiopathic arthritis: a randomized trial. J Rheum 2005; 32 (5): 943-950
45. Prieur AM. The place of corticosteroid therapy in juvenile chronic arthritis in 1992. J Rheumatol 1993; 37: 32-34
46. Rasnake LK, Mervis K, Belpedio K et al. Child and parent perceptions of child health-related quality of life in rheumatic disease: discrepancies and congruencies for ill and well dyads. Pediatric Rheumatology Online Journal 2003; 1: 187
47. Reiff A, Rawlings DJ, Shaham B et al. Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis. J Rheumatol 1997; 24: 2436-2443
48. Riddle R, Ryser CN, Morton AA et al. The impact on health-related quality of life from non-steroidal anti-inflammatory drugs, methotrexate, or steroids in treatment for juvenile idiopathic arthritis. J Pediatr Psychol 2006; 31 (3): 262-271. Epub 2005 May 4
49. Ruperto N et al. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum 2007; 56 (9): 3096-3106
50. Ruperto N, Kuzmina H, Pachanov E et al. A randomized trial off two dose regimen of meloxicam compared to naproxen oral suspension in juvenile idiopathic arthritis. Arthritis Rheum 2003; 48 (9 (Suppl.): S90-S91
51. Ruperto N, Murray KJ, Gerloni V et al. Pediatric Rheumatology International Trials Organization: A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum 2004; 50: 2191-2201
52. Sanden S et al. Glucocorticoid dose dependent downregulation of glucocorticoid receptors in patients with rheumatic diseases. J Rheumatol 2000; 27: 1265-1270
53. Schaller JG. Corticosteroids in juvenile rheumatoid arthritis. Arthritis Rheum 1977; 20 (Suppl 2): 537-543
54. Selbmann HK, Kopp I. Implementierung von Leitlinien in den Versorgungsalltag. Die Psychiatrie 2005; 1 (2): 33-38
55. Silverman E, Mouy R, Spiegel L et al. Leflunomide in Juvenile Rheumatoid Arthritis (JRA) Investigator Group: Leflunomide or methotrexate for juvenile rheumatoid arthritis. N Engl J Med 2005; 352: 1655-1666
56. Simon D et al. Linear growth in children suffering from juvenile idiopatic arthritis requiring steroid therapy: natural history and effect of growth hormone treatment on linear growth. J Pediatr Endocrinol Metab 2001; 14 (Suppl 6): 1483-1486
57. Singh-Grewal D, Wright V, Bar-Or O et al. Pilot study of fitness training and exercise testing in polyarticular childhood arthritis. Arthritis Rheum 2006; 55: 364-372
58. Singh-Grewal D. The effects of vigorous exercise training on physical function in children with arthritis: a randomized, controlled, single-blinded trial Arthritis Rheum 2007; 57 (7): 1202-1210
59. Stoeber E, Sänger L. Erfahrungen mit Indometazin in der Langzeittherapie der juvenilen rheumatoiden Arthritis. Arzneimittelforschung 1971; 21 (11): 1865-1866
60. Stritter FT, Tresolini CP, Reeb KG. The Delphi Technique in Curriculum Development. Teaching and Learning in Medicine 1994; 6 (2): 136-141
61. Takken T, Der Net J Van, Kuis W et al. Aquatic fitness training for children with juvenile idiopathic arthritis. Rheumatology (Oxford) 2003; 1408-1414
62. Takken T, Net J Van der, Kuis W et al. Physical activity and health related physical fitness in children withjuvenileidiopathicarthritis. Ann Rheum Dis 2003; 62 (9): 885-889
63. Toledo MM, Martini G, Gigante C et al. Is there a role for arthroscopic synovectomy in oligoarticular juvenile idiopathic arthritis? J Rheumatol 2006; 33: 1868-1872
64. Rossum MA van, Fiselier TJ, Franssen MJ et al. Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study Dutch Juvenile Chronic Arthritis Study Group. Arthritis Rheum 1998; 41: 808-816
65. Rossum MA van, Fiselier TJ, Franssen MJ et al. Long-term outcome of Juvenile Idiopathic Arthritis following a placebo controlled trial: sustained benefits of early sulfasalazin treatment. Dutch Juvenile Chronic Arthritis Study Group. Arthritis Rheum Dis 2007; 66: 1518-1524
66. Schnakenburg K von et al. Leitlinien Kinder- und Jugendmedizin. Rheumatologie Abschnitt H1: 1-15, Elsevier, 11. Lieferung; 2005
67. Wagner N. Juvenile idiopathische Arthritis - Medikamentöse Therapie. In Bassler/Forster/Antes Evidenz basierte Pädiatrie, 1, Auflage. Thieme Verlag; 2001
68. Yokota S et al. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet 2008; 371 (9617): 998-1006
69. Zulian F et al. Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis. Rheumatology 2003; 42: 1254-1259
70. Zulian F, Martini G, Gobber D et al. Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial. Rheumatology (Oxford) 2004; 43 (10): 1288-1291. Epub 2004 Jul 13